Mary Tagliaferri

Dr. Mary A.
Tagliaferri, MD, is an Independent Director at Y-mAbs Therapeutics, Inc., an Independent Director at Enzo Biochem, Inc. and a Chief Medical Officer & Senior Vice President at Nektar Therapeutics.
She is on the Board of Directors at Y-mAbs Therapeutics, Inc. and Enzo Biochem, Inc. Dr. Tagliaferri was previously employed as an Independent Director by Rayzebio, Inc., a Chief Medical Officer by Kanglaite USA, Inc., a President, Secretary, Treasurer & Director by Bionovo, Inc., and a Secretary, Treasurer & Chief Regulatory Officer by Lighten Up Enterprises International, Inc. She also served on the board at Atossa Therapeutics, Inc. She received her undergraduate degree from Cornell University, a graduate degree from American College of Traditional Chinese Medicine and a doctorate degree from The University of California, San Francisco.